A capable and compatible partner is critical for success. We advise clients on planning, identifying and evaluating candidates for alliances, joint ventures and M&A with companies in China.

We help our clients identify, screen and evaluate generic technologies and new drug leads in China, and then help them negotiate acquisition, licensing, co-development and strategic alliance deals. We also assist clients in licensing-out their products to Chinese companies.